Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovodak (Sofosbuvir/Daclatasvir) in HCV/HIV Co-infected Patients
NCT03369327Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir, daclatasvir in hepatitis C (HCV), sponsored by Tehran University of Medical Sciences. Started Jan 2017; status: completed.
02
Drugs
sofosbuvirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03369327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369327.